On April 8, 2022 InDex Pharmaceuticals Holding AB (publ) reported the Annual Report for 2021 (Press release, InDex Pharmaceuticals, APR 8, 2022, View Source [SID1234611650]). The Annual Report is attached as a PDF and is available on the company’s website, View Source

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Annual Report is mailed to shareholders and other stakeholders who specifically request it. Send request to [email protected], or by mail to InDex Pharmaceuticals Holding AB (publ), Berzelius väg 13, 171 65 Solna, Sweden.

Publication
The information was submitted for publication through the agency of the contact person set out above at 13:20 CET on April 8, 2022.